Pfizer, Novartis, Roche, GSK Japan Units Plan Local Cancer Drug Efforts
This article was originally published in PharmAsia News
Executive Summary
Pfizer Japan, Novartis Pharma KK, Chugai Pharmaceutical, GlaxoSmithKline KK and other Japan subsidiaries or allies of foreign drug makers are planning to introduce new cancer drugs in the country.